「ADRENERGIC」の共起表現一覧(1語右で並び替え)
該当件数 : 83件
odafinil possesses greater selective alpha-1 | adrenergic activity than adrafinil without the side eff |
If the amine on the | Adrenergic agent has a substituent bigger than a tertia |
stituted phenethylamines are known to act as | adrenergic agents (including adrenergic uptake inhibito |
vity or idiosyncrasy to their components, to | adrenergic agents or to other drugs of similar chemical |
The pharmacologic effects of beta | adrenergic agonist drugs, such as orciprenaline, are at |
ptor agonist and also has some serotonin and | adrenergic agonist effects, as well as some anticholine |
Adrenergic agonists or withdrawal from alpha blockers ( | |
It has the opposite effect as | adrenergic agonists. |
ine, and similarly to it, has effects on the | adrenergic and dopaminergic systems. |
ne and dopamine and therefore an increase in | adrenergic and dopaminergic neurotransmission. |
compensatory changes at dopamine, serotonin, | adrenergic and histamine receptor sites in the central |
An | Adrenergic antagonist is a pharmaceutical substance tha |
of beta-1 (ADRB1) may affect the response to | adrenergic beta-antagonist treatment of heart failure. |
cells), Ca2+ channel antagonistic action, α1 | adrenergic blockade and others. |
Guanadrel is a postganglionic | adrenergic blocking agent. |
Pirbuterol (trade name: Maxair) is a beta-2 | adrenergic bronchodilator used in the treatment of asth |
n primarily by increasing catecholaminergic ( | adrenergic, dopaminergic) and histaminergic activity in |
indicate that etilefrine has both β1 and α1 | adrenergic effects in man. |
ke inhibitor and has negligible affinity for | adrenergic, histaminergic, and muscarinic receptors. |
hypotension) which is followed by sustained | adrenergic hyperactivity (hypertension, tachycardia, an |
Adrenergic means "having to do with adrenaline (epineph | |
or a variety of dopaminergic, serotonergic, | adrenergic, muscarinic or cannabinoid receptors and doe |
ter release from sympathetic nerves and from | adrenergic neurons in the central nervous system. |
Effects on the body include cholinergic, | adrenergic, opioid and nitric oxide donating actions, a |
The | adrenergic phase but not the cholinergic phase is a dos |
Adrenergic receptor | |
The | Adrenergic receptor Pathways |
Adrenergic receptor agonist | |
Adrenergic receptor antagonist | |
Alpha-1 | adrenergic receptor |
It is a subtype of the | adrenergic receptor family. |
ICI-118,551 is a selective beta-2 (β2) | adrenergic receptor antagonist. |
Beta-3 | adrenergic receptor has been shown to interact with Src |
Beta | adrenergic receptor kinase-2 appears to affect dopamine |
ine is a nonselective agonist of the alpha-1 | adrenergic receptor (α1-AR), and an antagonist to the a |
The alpha-2A | adrenergic receptor (α2A adrenoceptor), also known as A |
Overall, the beta | adrenergic receptor kinase 2 has 85% amino acid similar |
Systemic Alpha-1 | adrenergic receptor antagonists have been implicated in |
(steps 1) Upon stimulation of the Beta | adrenergic receptor by epinephrine, Gs will be activate |
Beta | adrenergic receptor kinase has been shown to interact w |
is a cardiotonic drug which acts as a Beta-1 | adrenergic receptor agonist. |
The alpha-2B | adrenergic receptor (α2B adrenoceptor), is a G-protein |
The alpha-1 (α1) | adrenergic receptor is a G protein-coupled receptor (GP |
Beta | adrenergic receptor kinase (also referred to as βARK or |
It acts as both a selective α2 | adrenergic receptor antagonist, and an antagonist for t |
ent and selective antagonist for the Alpha-1 | adrenergic receptor subtype α1B. |
Adrenergic receptor antagonist, subtypes α2a and α2c: c | |
The beta | adrenergic receptor kinase-2 was cloned from mice and r |
It is an alpha-1 | adrenergic receptor blocker that inhibits the binding o |
, did not find that the gene coding for beta | adrenergic receptor kinase-2 was linked to schizophreni |
he NMDA antagonist tiletamine or the alpha-2 | adrenergic receptor agonist xylazine, depending on what |
a2A-adrenoceptor (also known as the alpha-2A | adrenergic receptor) has been shown to improve working |
t acts as a selective antagonist for the α2B | adrenergic receptor, and has been useful for distinguis |
research to understand the action of the β2 | adrenergic receptor, as few other specific antagonists |
, GAB1, MST1R, DNM1, Huntingtin, Src, Beta-2 | adrenergic receptor, VAV2, ADAM15, RAPGEF1, VAV1, HER2/ |
onidine, it is an agonist at the α2 class of | adrenergic receptor. |
which acts as a selective agonist for the β3 | adrenergic receptor. |
nist at both the 5-HT1A receptor and the α2C | adrenergic receptor. |
which acts as a selective agonist for the β3 | adrenergic receptor. |
of drugs that bind selectively to the beta-1 | adrenergic receptor. |
2 dopamine receptor and antagonist at the α1 | adrenergic receptor. |
fect on heart muscle, when binding to beta-1 | adrenergic receptors on this tissue. |
Beta | adrenergic receptors are involved in the epinephrine- a |
regulated by norepinephrine (noradrenaline) ( | adrenergic receptors), whereas parasympathetic systems |
thylclonidine is an irreversible agonist for | adrenergic receptors, in particular alpha1B, D, C and a |
ated via a partial agonist action at Alpha-2 | adrenergic receptors, and TDIQ has been suggested as a |
y blocking a variety of receptors, including | adrenergic receptors, dopamine receptors, histamine rec |
It stimulates | adrenergic receptors. |
It has no effect on alpha or beta | adrenergic receptors. |
nzamine forms a permanent covalent bond with | adrenergic receptors. |
metic that nonselectively agonizes α1 and α2 | adrenergic receptors. |
t also interacts centrally with dopamine and | adrenergic receptors. |
upling in the rat parotid gland and at alpha | adrenergic receptors. |
tivated through protein receptors such as α1 | adrenergic receptors. |
hilic side-chain that binds to an exosite on | adrenergic receptors. |
oson vasodilates but does not stimulate beta | adrenergic receptors. |
mals, suggesting stimulation of both α and β | adrenergic receptors. |
de, where they can come into contact with β2 | adrenergic receptors. |
Adrenergic reuptake inhibitor | |
and thereby rendering it less responsive to | adrenergic stimulation ). |
ppear to be mediated by the dopaminergic and | adrenergic systems. |
It localizes to | adrenergic tissue and thus can be used to identify the |
Adrenergic transporter | |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |